Article
CDH17 Is a More Sensitive Marker for Gastric Adenocarcinoma Than CK20 and CDX2
28 Dec 2016
Abstract excerpt
CONTEXT: -CDH17, which is expressed in the intestinal epithelium, is a novel oncogene involved in tumor invasion and metastasis. A panel consisting of cytokeratin (CK) 7, CD20, and CDX2 antibodies is typically used to diagnose gastrointestinal adenocarcinomas. However, studies have shown that CDH17 is a highly specific marker for gastrointestinal adenocarcinoma and may be important in clinical diagnosis....
Topics
Join the communities discussing this publication.